BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Titan Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524717
ISIN Demat
INE150C01029
Book Value (Rs)
41.3474594
NSE Symbol
N.A
Divident Yield %
0.12
Market Cap
(Rs In Cr.)
1,681
P/E (TTM)
54.69
EPS (TTM)
7.44
Face Value
(Rs)
2
Back
Titan Biotech consolidated net profit rises 58.31% in the June 2026 quarter
14-Aug-26   Hrs IST

Net profit of Titan Biotech rose 58.31% to Rs 10.86 crore in the quarter ended June 2026 as against Rs 6.86 crore during the previous quarter ended June 2025. Sales rose 27.25% to Rs 59.17 crore in the quarter ended June 2026 as against Rs 46.50 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales59.1746.50 27
OPM %21.1118.80 -
PBDT14.109.26 52
PBT12.738.11 57
NP10.866.86 58

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)